Full Press Release Details
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals.
LXRX
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
Key Takeaway: Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
Price reaction · baseline $1.58 (2024-04-26 close) · 1 other LXRX headline(s) in the window, move may be shared
day 0 close
-1.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus